Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Am J Clin Nutr ; 63(2): 261-6, 1996 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8561069

RESUMO

Recent data suggest that treatment with n-3 fatty acids could enhance the susceptibility of plasma low-density-lipoprotein (LDL) to oxidation. Twelve hypertriacylglycerolemic, hemodialyzed patients were treated with 2.5 g n-3 fatty acids/d for 2 mo. Treatment was then withdrawn for 2 mo (washout phase). Plasma total cholesterol and LDL cholesterol increased significantly (9% and 28%) and plasma triacylglycerols decreased significantly after the n-3 phase compared with baseline and washout values. LDL susceptibility to oxidation was tested by oxidation of LDL particles with 2,2'-azobis (2-amidinopropane) dihydrochloride (AAPH). No significant changes were observed for the lag phase and the peroxidation rate. The vitamin E content of LDL also did not change significantly. The results thus suggest that a daily dosage of 2.5 g n-3 fatty acids does not enhance LDL susceptibility to oxidation, while retaining its hypotriacylglycerolemic effect.


Assuntos
LDL-Colesterol/sangue , Ácidos Graxos Ômega-3/uso terapêutico , Hipertrigliceridemia/sangue , Falência Renal Crônica/sangue , Peroxidação de Lipídeos/efeitos dos fármacos , Diálise Renal , Amidinas/farmacologia , Colesterol/sangue , HDL-Colesterol/sangue , Ácidos Graxos Ômega-3/farmacologia , Feminino , Humanos , Hipertrigliceridemia/terapia , Falência Renal Crônica/terapia , Masculino , Pessoa de Meia-Idade , Triglicerídeos/sangue , Vitamina E/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA